IP-10 and type 1 diabetes: A question of time and location

Autoimmunity

Volumn 37, Issue 4, 2004, Pages 273-282

  Christen, Urs ^a   von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoimmune diseases; Chemokines; Diabetes; IP 10

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, HUMAN; CXCR3 PROTEIN, MOUSE; GLYCOPROTEIN; NUCLEOPROTEIN; VIRUS PROTEIN;

ANTIGEN SPECIFICITY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE ACTIVATION; TIME; ANIMAL; DISEASE MODEL; GENE VECTOR; GENETICS; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; MOUSE; PANCREAS ISLET; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; ANTIGENS; CHEMOKINES, CXC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; INFLAMMATION; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES; CHEMOKINE CXCL10; GENETIC VECTORS; GLYCOPROTEINS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEINS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; VIRAL PROTEINS;

EID: 4444250373     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930410001713124     Document Type: Review

References (99)

1. Keegan, B.M. and Noseworthy, J.H. (2002) "Multiple sclerosis", Annu. Rev. Med. 53, 285-302.
2. Feldmann, M., Brennan, F.M. and Maini, R.N. (1996) "Rheumatoid arthritis", Cell 85, 307-310.
3. Manns, M.P., Johnson, E.F., Griffin, K.J., Tan, E.M. and Sullivan, K.F. (1989) "Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1", J. Clin. Invest. 83, 1066-1072.
4. Bach, J.F. and Chatenoud, L. (2001) "Tolerance to islet autoantigens in type 1 diabetes", Annu. Rev. Immunol. 19, 131-161.
5. Nepom, G.T. (1995) "Class II antigens and disease susceptibility", Anna. Rev. Med. 46, 17-25.
6. Holmdahl, R. (1998) "Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis", Curr. Opin. Immunol. 10, 710-717.
7. Davies, J.L., Kawaguchi, Y., Bennett, S.T., Copeman, J.B., Cordell, H.J., Pritchard, L.E., et al. (1994) "A genome-wide search for human type 1 diabetes susceptibility genes", Nature 371, 130-136.
8. Pitkanen, J. and Peterson, P. (2003) "Autoimmune regulator: from loss of function to autoimmunity", Genes Immun. 4, 12-21.
9. Kuchroo, V.K., Umetsu, D.T., DeKruyff, R.H. and Freeman, G.J. (2003) "The TIM gene family: emerging roles in immunity and disease", Nat. Rev. Immunol. 3, 454-462.
10. Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., et al. (2003) "Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease", Nature 423, 506-511.
11. Kallmann, B.A., Lampeter, E.F., Hanifi-Moghaddam, P., Hawa, M., Leslie, R.D. and Kolb, H. (1999) "Cytokine secretion patterns in twins discordant for Type I diabetes", Diabetologia 42,1080-1085.
12. Redondo, M.J., Rewers, M., Yu, L., Garg, S., Pilcher, C.C., Elliott, R.B., et al. (1999) "Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study", BMJ 318, 698-702.
13. Thomson, G., Robinson, W.P., Kuhner, M.K., Joe, S., MacDonald, M.J., Gottschall, J.L., et al. (1988) "Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus", Am. J. Hum. Genet. 43, 799-816.
14. Yoon, J.W., Ihm, S.H. and Kim, K.W. (1989) "Viruses as a triggering factor of type 1 diabetes and genetic markers related to the susceptibility to the virus-associated diabetes", Diabetes Res. Clin. Pract. 1, S47-S58.
15. Honeyman, M.C., Coulson, B.S., Stone, N.L., Gellert, S.A., Goldwater, P.N., Steele, C.E., et al. (2000) "Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes", Diabetes 49, 1319-1324.
16. Notkins, A.L. and Yoon, J.-W. (1984) "Virus-induced diabetes mellitus:, In: Notkins, A.L. and Oldstone, M.B.A., eds, Concepts in Viral Pathogenesis (Springer-Verlag, New York), pp 241-247.
17. Notkins, A.L., Yoon, J.-W., Onodera, T., Toniolo, A. and Jenson, A.B. (1981) "Virus-induced diabetes mellitus", Perspect. Virol. 11, 141-162.
18. von Herrath, M.G., Holz, A., Homann, D. and Oldstone, M.B. (1998) "Role of viruses in type I diabetes", Semin. Immunol. 10, 87-100.
19. von Herrath, M.G. (2000) "Obstacles to identifying viruses that cause autoimmune disease", J. Neuroimmunol. 107, 154-160.
20. Oldstone, M.B.A., Nerenberg, M., Southern, P., Price, J. and Lewicki, H. (1991) "Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response", Cell 65, 319-331.
21. Ohashi, P., Oehen, S., Buerki, K., Pircher, H., Ohashi, C., Odermatt, B., et al. (1991) "Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice", Cell 65, 305-317.
22. von Herrath, M.G., Dockter, J. and Oldstone, M.B.A. (1994) "How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model", Immunity 1, 231-242.
23. McGavern, D.B., Christen, U. and Oldstone, M.B. (2002) "Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo", Nat. Immunol. 3, 918-925.
24. Christen, U., McGavern, D.B., Luster, A.D., von Herrath, M.G. and Oldstone, M.B. (2003) "Among CXCR3 chemokines, IFN-gamma-inducible protein of 10kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease", J. Immunol. 171, 6838-6845.
25. Petersen, J.S., Bregenholt, S., Apostolopolous, V., Homann, D., Wolfe, T., Hughes, A., et al. (2003) "Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes", Clin. Exp. Immunol. 134, 38-45.
26. von Herrath, M.G., Dyrberg, T. and Oldstone, M.B.A. (1996) "Oral insulin treatment suppresses virus-induced antigen-specific destruction of b-cells and prevents autoimmune diabetes in transgenic mice", J. Clin. Invest. 98, 1324-1331.
27. Coon, B., An, L.-L., Whitton, J.L. and von Herrath, M.G. (1999) "DNA immunization to prevent autoimmune diabetes", J. Clin. Invest. 104, 189-194.
28. von Herrath, M.G. and Whitton, J.L. (2000) "DNA vaccination to treat autoimmune diabetes", Ann. Med. 32, 285-292.
29. von Herrath, M.G. and Oldstone, M.B.A. (1997) "Interferon-g is essential for destruction of b-cells and development of insulin-dependent diabetes mellitus", J. Exp. Med. 185, 531-539.
30. Liblau, R.S., Singer, S.M. and McDevitt, H. (1995) "Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases", Immunol. Today 16, 34-38.
31. Christen, U., Wolfe, T., Mohrle, U., Hughes, A.C., Rodrigo, E., Green, E.A., et al. (2001) "A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis", J. Immunol. 166, 7023-7032.
32. Seewaldt, S., Thomas, H., Ejrnaes, M., Christen, U., Wolfe, T., Rodrigo, E., et al. (2000) "Virus-induced autoimune diabetes: Most b-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) CTL", Diabetes 49, 1801-1809.
33. Charlton, B. and Lafferty, K.J. (1995) "The Th1/Th2 balance in autoimmunity", Curr. Opin. Immunol. 7, 793-798.
34. Han, H.S., Jun, H.S., Utsugi, T. and Yoon, J.-W. (1997) "Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T-cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice", J. Autoimmun. 10, 299-307.
35. Haneda, K., Sano, K., Tamura, G., Sato, T., Habu, S. and Shirato, K. (1997) "TGF-b induced by oral tolerance ameliorates experimental tracheal eosinophilia" J. Immunol. 159, 4686-4690.
36. Gianani, R. and Sarvetnick, N. (1996) "Viruses, cytokines, antigens, and autoimmunity", Proc. Natl Acad. Sci. USA 93, 2257-2259.
37. Lafaille, J.J., Van de Kerre, F., Hsu, A.L., Baron, J.L., Haas, W., Raine, C.S., et al. (1997) "Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease", J. Exp. Med. 186, 307-312.
38. McSorley, S.J., Soldera, S., Malherbe, L., Carnaud, C., Locksley, R.M., Flavell, R.A., et al. (1997) "Immunological tolerance to a pancreatic antigen as a result of local expression of TNFa by islet b cells", Immunity 7, 401-409.
39. Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O., Rajotte, R.V. and Power, R.F. (1997) "TNF-a down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice", J. Immunol. 159, 6298.
40. Garside, P., Steel, M., Worthey, A., Satoskar, A., Alexander, J., Bluethmann, H., et al. (1995) "T helper 2 cells at subject to high dose oral tolerance and are not essential for its induction", J. Immunol. 154, 5649-5655.
41. Christen, U., Benke, D., Wolfe, T., Rodrigo, E., Rhode, A., Hughes, A.C., et al. (2004) "Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient" , J. Clin. Invest. 113, 74-84.
42. Rabinovitch, A. (1998) "An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus", Diabetes Metab. Rev. 14, 129-151.
43. Sarvetnick, N., Liggitt, D., Pitts, S.L., Hansen, S.E. and Stewart, T.A. (1988) "Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma", Cell 52, 773-782.
44. Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., et al. (1990) "Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma", Nature 346, 844-847.
45. Allison, J., Oxbrow, L. and Miller, J.F. (1994) "Consequences of in situ production of IL-2 for islet cell death", Int. Immunol. 6, 541-549.
46. von Herrath, M.G., Allison, J., Miller, J.F. and Oldstone, M.B. (1995) "Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response", J. Clin. Invest. 95, 477-485.
47. Guerder, S., Picarella, D.E., Linsley, P.S. and Flavell, R.A. (1994) "Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice", Proc. Natl Acad. Sci. USA 91, 5138-5142.
48. Green, E.A., Wong, F.S., Eshima, K., Mora, C. and Flavell, R.A. (2000) "Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells", J. Exp. Med. 191, 225-238.
49. Green, E.A., Eynon, E.E. and Flavell, R.A. (1998) "Local expression of TNFa in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens", Immunity 9, 733-743.
50. Allison, J., McClive, P., Oxbrow, L., Baxter, A., Morahan, G. and Miller, J.F. (1994) "Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells", Eur. J. Immunol. 24, 2535-2541.
51. Mueller, R., Bradley, L.M., Krahl, T. and Sarvetnick, N. (1997) "Mechanism underlying counterregulation of autoimmune diabetes by IL-4", Immunity 7, 411-418.
52. Mueller, R.T. and Sarvetnick, N. (1996) "Pancreatic expression of IL-4 abrogates insulitis and diabetes in NOD mice", J. Exp. Med. 184, 1093-1099.
53. Gallichan, W.S., Balasa, B., Davies, J.D. and Sarvetnick, N. (1999) "Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse", J Immunol. 163, 1696-1703.
54. Moritani, M., Yoshimoto, K., Wong, S.F., Tanaka, C., Yamaoka, T., Sano, T., et al. (1998) "Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1", J. Clin. Invest. 102, 499-506.
55. Sanvito, F., Nichols, A., Herrera, P.L., Huarte, J., Wohlwend, A., Vassalli, J.D., et al. (1995) "TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes", Biochem. Biophys. Res. Commun. 217, 1279-1286.
56. Juedes, A.E., Asseman, C., Togher, L., Peng, Y., Green, E.A., Flavell, R.A., et al. (2004) "TGF-b enhances autoimmune diabetes by increasing survival of memory effector CD8 lymphocytes", Submitted for publication.
57. Grewal, I.S., Grewal, K.D., Wong, S., Picarella, D.E., Janeway, C.A. and Flavell, R.A. (1996) "Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells", J. Exp. Med. 184, 1963-1974.
58. Balasa, B., DJ, D., Lee, J., Good, A., Yeung, B.T. and Sarvetnick, N. (1998) "IL-10 impacts autommume diabetes via a CD8+ T cell pathway circumventing the recuirement for CD4+ T and B lymphocytes", J. Immunol. 161, 4420-4427.
59. Balasa, B., Van Gunst, K., Jung, N., Balakrishna, D., Santamaria, P., Hanafusa, T., et al. (2000) "Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules", J. Immunol. 165, 2841-2849.
60. Wogensen, L., Lee, M.S. and Sarvetnick, N. (1994) "Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice" , J. Exp. Med. 179, 1379-1384.
61. Green, E.A. and Flavell, R.A. (2000) "The temporal importance of TNFalpha expression in the development of diabetes", Immunity 12, 459-469.
62. Baggiolini, M., Dewald, B. and Moser, B. (1997) "Human chemokines: An update", Annu. Rev. Immunol. 15, 675-705.
63. Rossi, D. and Zlotnik, A. (2000) "The biology of chemokines and their receptors", Annu. Rev. Immunol. 18, 217-242.
64. Sallusto, F., Mackay, C.R. and Lanzavecchia, A. (2000) "The role of chemokine receptors in primary, effector, and memory immune responses", Annu. Rev. Immunol. 18, 593-620.
65. Luster, A.D. (1998) "Chemokines - Chemotactic cytokines that mediate inflammation", N. Engl. J. Med 338, 436-445.
66. O'Garra, A., McEvoy, L.M. and Zlotnik, A. (1998) "T-cell subsets: chemokine receptors guide the way", Curr. Biol. 8, R646-R649.
67. Zlotnik, A. and Yoshie, O. (2000) "Chemokines: a new classification system and their role in immunity", Immunity 12, 121-127.
68. Sallusto, F., Lenig, D., Mackay, C.R. and Lanzavecchia, A. (1998) "Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes", J. Exp. Med. 187, 875-883.
69. Bonecchi, R., Bianchi, G., Bordignon, P.P., D'Ambrosio, D., Lang, R., Borsatti, A., et al. (1998) "Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s", J. Exp. Med. 187, 129-134.
70. Loetscher, P, Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., et al. (1998) "CCR5 is characteristic of Th1 lymphocytes", Nature 391, 344-345.
71. Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., et al. (1999) "Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine", Int. Immunol. 11, 81-88.
72. D'Ambrosio, D., Iellem, A., Bonecchi, R., Mazzeo, D., Sozzani, S., Mantovani, A., et al. (1998) "Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells", J. Immunol. 161, 5111-5115.
73. Bradley, L.M., Asensio, V.C., Schioetz, L.K., Harbertson, J., Krahl, T., Patstone, G., et al. (1999) "Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmume diabetes", J. Immunol. 162, 2511-2520.
74. Luster, A.D., Unkeless, J.C. and Ravetch, J.V. (1985) "Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins", Nature 315, 672-676.
75. Luster, A.D. and Ravetch, J.V. (1987) "Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)", J. Exp. Med. 166, 1084-1097.
76. Gattass, C.R., King, L.B., Luster, A.D. and Ashwell, J.D. (1994) "Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes", J. Exp. Med. 179, 1373-1378.
77. Liu, M.T., Chen, B.P., Oertel, P., Buchmeier, M.J., Armstrong, D., Hamilton, T.A., et al. (2000) "The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease", J. Immunol. 165, 2327-2330.
78. Asensio, V.C. and Campbell, I.L. (1997) "Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis" , J. Virol. 71, 7832-7840.
79. Kolb, S.A., Sporer, B., Lahrtz, F., Koedel, U., Pfister, H.W. and Fontana, A. (1999) "Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10", J. Neuroimmunol. 93, 172-181.
80. Hoffman, L.M., Fife, B.T., Begolka, W.S., Miller, S.D. and Karpus, W.J. (1999) "Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease", J Neurovirol. 5, 635-642.
81. Charles, P.C., Chen, X., Horwitz, M.S. and Brosnan, C.F. (1999) "Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice", J. Neurovirol. 5, 55-64.
82. Lane, T.E., Asensio, V.C., Yu, N., Paoletti, A.D., Campbell, I.L. and Buchmeier, M.J. (1998) "Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease", J. Immunol. 160, 970-978.
83. Taub, D.D., Sayers, T.J., Carter, C.R. and Ortaldo, J.R. (1995) "Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis", J. Immunol. 155, 3877-3888.
84. Taub, D.D., Longo, D.L. and Murphy, W.J. (1996) "Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues of human peripheral blood lymphocytes-SCID mice", Blood 87, 1423-1431.
85. Sallusto, F., Lanzavecchia, A. and Mackay, C.R. (1998) "Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses", Immunol. Today 19, 568-574.
86. Loetscher, M., Gerber, B., Loetscher, P., Jones, S.A., Piali, L., Clark-Lewis, I., et al. (1996) "Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated lymphocytes", J. Exp. Med. 184, 963-969.
87. Khan, I.A., MacLean, J.A., Lee, F.S., Casciotti, L., DeHaan, E., Schwartzman, J.D., et al. (2000) "IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection", Immunity 12, 483-494.
88. Luster, A.D., Cardiff, R.D., MacLean, J.A., Crowe, K. and Granstein, R.D. (1998) "Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine", Proc. Assoc. Am. Physicians 110, 183-196.
89. von Herrath, M.G. and Holz, A. (1997) "Pathological changes in the islet miliue precede infiltration of islets and destruction of b-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM", J. Autoimmun. 10, 231-238.
90. Cox, M.A., Jenh, C.H., Gonsiorek, W., Fine, J., Narula, S.K., Zavodny, P.J., et al. (2001) "Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemo-attractant are allotopic ligands for human CXCR3: differential binding to receptor states", Mol. Pharmacol. 59, 707-715.
91. Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Hollander, G.A., et al. (2002) "beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis", Nat. Med. 8, 1414-1420.
92. Rhode, A., Pauza, M., Barral, A., Oldstone, M.B.A., von Herrath, M.G. and Christen, U. (2004) "Islet-specific expression of IP-10 (CXCL10] targets lymphocytes to the pancreas and accelerates type 1 diabetes", Submitted.
93. Cardozo, A.K., Proost, P., Gysemans, C., Chen, M.C., Mathieu, C. and Eizirik, D.L. (2003) "IL-lbeta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice", Diabetologia 46, 255-266.
94. Picarella, D.E., Kratz, A., Li, C., Ruddle, N. and Flavell, R.A. (1993) "Transgenic tumour necrosis factor (TNF)-a production in pancreatic islets leads to insulitis, not diabetes", J. Immunol. 150, 4136-4150.
95. Holz, A., Brett, K. and Oldstone, M.B. (2001) "Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoinumme diabetes", J. Clin. Invest. 108, 1749-1758.
96. Allison, J., Malcolm, L., Chosich, N. and Miller, J.F. (1992) "Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells" , Eur. J. Immunol. 22, 1115-1121.
97. Ejrnaes, M., Videbaek, N., Christen, U., Michelsen, B. and von Herrath, M.G. (2004) "Different diabetogenic potential of autoaggressive CD8+ clones associated with CXCL10 production but not cytokine expression, cytolytic activity or homing characteristics", Submitted for publication.
98. Oldstone, M.B. (1990) "Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence", J. Exp. Med. 171, 2077-2089.
99. Christen, U., Darwiche, R., Thomas, H.E., Wolfe, T., Rodrigo, E., Chervonsky, A., et al. (2004) "Virally induced inflammation triggers fratricide of Fas-ligand-expressing beta-cells", Diabetes 53, 591-596.